Literature DB >> 7635529

Theodore Cooper Memorial Lecture. Kallikreins and kinins. Some unanswered questions about system characteristics and roles in human disease.

H S Margolius1.   

Abstract

Kinins can affect many aspects of cellular function, but their roles in human homeostatic mechanisms and disease are just beginning to be understood. In this brief review, some of the interesting new observations about kallikrein-kinin system characteristics, roles in cell behavior, and aberrancy in diseases of relevance to readers interested in hypertension will be discussed. Along the way, questions raised by these observations will be posed. They show that we still have much to learn about the contributions of kinins to human cardiovascular diseases but now have in addition both a strong rationale for asking them and the tools to make them operational.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635529     DOI: 10.1161/01.hyp.26.2.221

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  19 in total

1.  Kallistatin is a potent new vasodilator.

Authors:  J Chao; J N Stallone; Y M Liang; L M Chen; D Z Wang; L Chao
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  Kininogen gene (KNG) variation has a consistent effect on aldosterone response to antihypertensive drug therapy: the GERA study.

Authors:  Maja Barbalic; Gary L Schwartz; Arlene B Chapman; Stephen T Turner; Eric Boerwinkle
Journal:  Physiol Genomics       Date:  2009-07-07       Impact factor: 3.107

Review 3.  Tissue kallikreins structure, regulation, and participation in mammalian physiology and disease.

Authors:  H S Margolius
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 4.  Protease-activated receptors in kidney disease progression.

Authors:  Oleg Palygin; Daria V Ilatovskaya; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2016-10-12

5.  The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts.

Authors:  J P Schanstra; E Bataillé; M E Marin Castaño; Y Barascud; C Hirtz; J B Pesquero; C Pecher; F Gauthier; J P Girolami; J L Bascands
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

6.  Novel mechanism of plasma prekallikrein (PK) activation by vascular smooth muscle cells: evidence of the presence of PK activator.

Authors:  J S Keum; M A Jaffa; L M Luttrell; A A Jaffa
Journal:  J Biol Regul Homeost Agents       Date:  2014 Oct-Dec       Impact factor: 1.711

7.  Association of the human bradykinin B2 receptor gene with chronic renal failure.

Authors:  Lucyna Jozwiak; Andrzej Drop; Kinga Buraczynska; Piotr Ksiazek; Piotr Mierzicki; Monika Buraczynska
Journal:  Mol Diagn       Date:  2004

8.  Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans.

Authors:  Michel Azizi; Pierre Boutouyrie; Alvine Bissery; Mohsen Agharazii; Francis Verbeke; Nora Stern; Alessandra Bura-Rivière; Stéphane Laurent; François Alhenc-Gelas; Xavier Jeunemaitre
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

9.  In vivo bradykinin B2 receptor activation reduces renal fibrosis.

Authors:  Joost P Schanstra; Eric Neau; Pascale Drogoz; Miguel A Arevalo Gomez; José Miguel Lopez Novoa; Denis Calise; Christiane Pecher; Michael Bader; Jean-Pierre Girolami; Jean-Loup Bascands
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

10.  Novel bradykinin signaling in adult rat cardiac myocytes through activation of p21-activated kinase.

Authors:  Yunbo Ke; Katherine A Sheehan; E Eroume A Egom; Ming Lei; R John Solaro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-02-12       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.